Contact Us
Drug Search Results
More Filters [+]

Lynestrenol

Alternative Names: lynestrenol
Latest Update: 2024-04-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: PR Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Chile | Colombia | Czech | Dominican Republic | Egypt | Finland | Germany | India | Indonesia | Ireland | Jordan | Lebanon | Luxembourg | Netherlands | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Serbia | Singapore | Slovenia | Spain | Sweden | Taiwan | Turkey | Ukraine | Uruguay | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Medical University of Vienna
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lynestrenol

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Gender Dysphoria

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
Effects of sex hormones on the serotonin system

P4

Completed

Gender Dysphoria

2022-05-31

AP13214ONB

P4

Completed

Gender Dysphoria

2014-01-01

Recent News Events

Date

Type

Title

04/01/2024

PubMed

 Progestins as a Contributing Factor to Hepatocellular Adenoma: A Case Series and Literature Review.

10/01/2023

PubMed

 Protein C and protein S deficiencies are associated with increased risk of deep vein thrombosis in pregnant women using oral contraceptives.

07/01/2023

PubMed

 Relationship of Ethinylestradiol/Drospirenone Prescription on Work Productivity and Activity Impairment Among Women With Menstruation-Related Symptoms: A Multicenter Prospective Observational Study.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions